ArticleBMC medical imaging2025
Impact of intravitreal aflibercept on ocular and periocular tissue elasticity: a shear wave elastography study in diabetic retinopathy.
Article in BMC medical imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Retrobulbar microvascular and biomechanical changes associated with axial elongation in myopic eyes.Scientific reports · 2026Article
- Evaluation of Changes in Ocular Tissue Elasticity Before and After Trabeculectomy Using Shear Wave Elastography.Journal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo investigate changes in ocular and periocular tissue elasticity using shear wave elastography (SWE) in eyes with diabetic retinopathy following intravitreal aflibercept injections, and to compare these findings with those of the untreated contralateral eyes.
methodsThis prospective study included 42 eyes from 21 patients (11 males and 10 females; mean age: 65.9 ± 5.0 years) diagnosed with type 2 diabetic retinopathy. The effected eyes of the patients underwent intravitreal aflibercept injection therapy. SWE was performed on both injected and contralateral eyes at baseline, on day 1, and one month post-injection, measuring the elasticity of the crystalline lens(CL), posterior vitreous (PV), optic disc head (ODH), and retrobulbar fat (RF). Changes in the injected eyes were analyzed over time and compared with those in the untreated contralateral eyes.
resultsNo statistically significant differences were found in the SWE values of the CL, PV, ODH, and RF between the injected and non-injected eyes at day 1 and one month post-injection (p > 0.05). Additionally, no significant changes were observed in the SWE values of the injected eyes across the baseline, day 1, and one-month post-injection (p > 0.05).
conclusionsA single intravitreal aflibercept injection does not significantly affect the elasticity of ocular and periocular structures as assessed by SWE. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.